Problems in the use of urinary hCG-beta-core as a tumor marker in gynecologic cancer.

Abstract

Urinary human chorionic gonadotrophin beta-core (hCG-betaC) was detected in 55-77% of gynecologic malignancies. The use of spot and early morning urine hCG-betaC as a tumor marker was explored with regard to the stability of the hCG-betaC level in serial spot urine samples collected within 24 hours and in early morning urine collected over 3 days. Thirteen… (More)

Topics

Cite this paper

@article{Ngan1995ProblemsIT, title={Problems in the use of urinary hCG-beta-core as a tumor marker in gynecologic cancer.}, author={H. Y. S. Ngan and W.S.B. Yeung and G.T.S. Cheng and L. Wong and S. F. de Madeiros and R. M. Norman and H. K. Ma}, journal={International journal of gynecological cancer : official journal of the International Gynecological Cancer Society}, year={1995}, volume={5 1}, pages={15-19} }